Company

Merrimack Pharmaceuticals, Inc.

Headquarters: Cambridge, MA, United States

Founded: 2000 in Cambridge, Massachusetts

Employees: 426

CEO: Mr. Gary L. Crocker M.B.A., MBA

NASDAQ: MACK

Market Cap

$189.8 Million

USD as of Jan. 1, 2024

Market Cap History

Merrimack Pharmaceuticals, Inc. Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Merrimack Pharmaceuticals, Inc. market capitalization over time

Evolution of Merrimack Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Merrimack Pharmaceuticals, Inc.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector:
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Detailed Description

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Merrimack Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MACK wb_incandescent

Stock: FSX: MP6N wb_incandescent

Stock: XSTU: MP6N wb_incandescent

Details

Headquarters:

One Broadway

14th Floor

Cambridge, MA 02142

United States

Phone: 617 441 1000